SCHEMBL7761823

SCHEMBL7761823

O=C(O)c1cccc(-c2ccc([N+](=O)[O-])cc2)c1OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
CTSV O60911 2/20 0.49
CTSL P07711 2/20 0.49
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP19A1 P11511 3/20 0.47
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
PTGES O14684 1/20 0.47
RAB9A P51151 3/20 0.46
NPC1 O15118 1/20 0.46
PPIA P62937 1/20 0.46
PTGER1 P34995 1/20 0.45
ALDH1A1 P00352 2/20 0.44
MCL1 Q07820 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PLA2G4B P0C869 1/20 0.44
MAOA P21397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30542024 0.88 MEN1 (0.50) MEN1KMT2ACTSVCTSLMAPT
SCHEMBL29052911 0.88 MEN1 (0.50) MEN1KMT2ACTSVCTSLMAPT
SCHEMBL8797209 0.86 PTGER1 (0.55) CTSVCTSLPTGER1ALDH1A1MCL1
SCHEMBL28160764 0.84 CYP19A1 (0.56) MEN1KMT2AMAPTKDM4ECYP19A1
SCHEMBL5471405 0.80 PTGER1 (0.56) CTSVCTSLPTGER1ALDH1A1MCL1
SCHEMBL1315389 0.80 PTGER1 (0.49) KDM4ECYP19A1CYP11B1CYP11B2PTGER1
SCHEMBL3093865 0.79 CTSV (0.58) MEN1KMT2ACTSVCTSLRAB9A
SCHEMBL20610267 0.79 MEN1 (0.55) MEN1KMT2AMAPTKDM4ECYP19A1
SCHEMBL2547080 0.78 MYC (0.56) MEN1KMT2ACTSVCTSLMAPT
SCHEMBL8980593 0.78 MAOB (0.49) MEN1KMT2ACTSVCTSLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1105416-A1 NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS Keystone Biomedical, Inc. (US) 2001-06-13 EP claimed
US-6063919-A ESTERIFICATION OF O-DEPROTECTED DIBENZYL EXOCHELIC ACID WITH BENZYL EPI-COBACTIN, HYDROGENOLYTICALLY REMOVING THE THREE BENZYL GROUPS TO FORM EXOCHELIN 786SM(R) KEYSTONE BIOMEDICAL, INC. (US) 2000-05-16 US claimed
WO-2000009547-A1 NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS KEYSTONE BIOMEDICAL, INC. (US) 2000-02-24 WO claimed
EP-1105416-A1 NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS Keystone Biomedical, Inc. (US) 2001-06-13 EP disclosed
US-6063919-A ESTERIFICATION OF O-DEPROTECTED DIBENZYL EXOCHELIC ACID WITH BENZYL EPI-COBACTIN, HYDROGENOLYTICALLY REMOVING THE THREE BENZYL GROUPS TO FORM EXOCHELIN 786SM(R) KEYSTONE BIOMEDICAL, INC. (US) 2000-05-16 US disclosed
WO-2000009547-A1 NOVEL PROCESS FOR THE SYNTHESIS OF EXOCHELINS KEYSTONE BIOMEDICAL, INC. (US) 2000-02-24 WO disclosed